SCHEMBL7643193

SCHEMBL7643193

NS(=O)(=O)c1c(COc2ccccc2)sc2c1OCO2

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA12 O43570 11/20 0.39
CA1 P00915 10/20 0.39
CA2 P00918 10/20 0.39
CA9 Q16790 10/20 0.39
CA7 P43166 5/20 0.39
CA4 P22748 1/20 0.39
CA5A P35218 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.34
PTGES2 Q9H7Z7 1/20 0.34
CA13 Q8N1Q1 1/20 0.33
GRM5 P41594 1/20 0.33
MAOB P27338 2/20 0.33
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7642248 0.74 PTGS2 (0.36) CA12CA1CA2CA7SMN1; SMN2
SCHEMBL6909701 0.67 ALDH1A1 (0.44) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL6913710 0.66 L3MBTL1 (0.37) CA12CA1CA2CA9CA7
SCHEMBL6908277 0.66 PTGS1 (0.41) CA12CA1CA2CA9CA7
SCHEMBL1128972 0.63 CA2 (0.51) CA12CA1CA2CA9CA7
SCHEMBL7977965 0.61 PTGS1 (0.42) CA12CA1CA2CA9CA7
SCHEMBL27821451 0.59 CYP1A2 (0.64) PTGES2KDM4EMEN1ALDH1A1KMT2A
SCHEMBL30296408 0.59 CA2 (0.46) CA12CA1CA2CA9CA7
SCHEMBL25179640 0.59 KCNH2 (0.48) SMN1; SMN2MAOBALDH1A1
SCHEMBL27029743 0.57 CA1 (0.52) CA12CA1CA2CA9CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6432994-B1 CARDIOVASCULAR DISORDERS, GLAUCOMA; ANTIINFLAMMATORY, WOUND HEALING, HYPOTENSIVE, ANTIASTHMATIC, AND ANTIANAPHYLACTIC AGENTS TEXAS BIOTECHNOLOGY CORPORATION 2002-08-13 US disclosed